Submission Details
| 510(k) Number | K143500 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 10, 2014 |
| Decision Date | February 06, 2015 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K143500 is an FDA 510(k) clearance for the Immunalysis Amphetamine Urine Enzyme Immunoassay, Immunalysis Amphetamine Urine Calibrator, Immunalysis Amphetamine Urine Control Set, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by Immunalysis Corporation (Pomona, US). The FDA issued a Cleared decision on February 6, 2015, 58 days after receiving the submission on December 10, 2014. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K143500 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 10, 2014 |
| Decision Date | February 06, 2015 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |